You are receiving this email as a subscriber to Pharmaceutical Executive |
| |
 |
|
Interested in Learning About Other Topics?
Give us your ideas for a Future Webcast or Podcast
|
| |
| Featured Webcasts: |
Thursday, October 7, 2010 at 12:00 PM ET
Geographic Segmentation Without Reorganization
Is it possible for pharmaceutical companies to develop and execute differentiated geographic strategies without resorting to radical organizational change? This webcast will demonstrate how newly available data enables marketing, sales and managed markets organizations to understand the relative importance or "sphere of influence" of physicians, managed care, and consumers in each distinct geographic area and will present a novel approach for managing these differences without reorganization.
|
| » Register Free! |
Sponsored by: Wolters Kluwer and Amundsen Group |
|
ON DEMAND
Release Higher Performance Through Business Analytics
High performing companies have discovered how to harness the power of predictive capabilities to deliver top line sales growth, make smarter decisions and achieve better results. Predictive analytics is cited as the next management discipline, but relative to other industries many pharmaceutical companies have been late adopters in embracing this movement. Release Higher Performance through Business Analytics will help corporate decision makers like you better understand why predictive analytics is a game changer for sales and marketing, how to address the unique challenges in adopting this discipline and overcome barriers to implementation. Join us for our video webcast and listen in as our expert panel debate and give insights into leadership, process, talent and technology for Next Generation Business Analytics.
|
| » Register Free! |
Sponsored by: SAS |
|
|
Aggregate Spend Management & Disclosure: Complicating Factors and Leading Practices
Since 2002, more than 20 states have introduced legislation requiring pharmaceutical and medical device manufacturers to disclose payments or exchanges of financial value to physicians and other healthcare professionals (HCPs). While states increasingly pass new and expanded legislation, the federal government is proposing to increase the scale of disclosure substantially. This white paper explores how companies can prepare for 50-state aggregate spend reporting by automating data capture, aggregation and reporting.
|
| » View Whitepaper |
|
Safety Document Exchange in the Global Clinical Research Environment
Serious Adverse Event (SAE) reporting can have severe repercussions both for patient safety and company reputation. By choosing a portal solution from a SaaS provider with state-of-the-art online security features, a sponsor or CRO can maintain real-time distribution and access reports for all documents shared, helping maintain compliance and data privacy.
|
| » View Whitepaper |
|
|
|
|
|
| Featured Content: |
|
Pharm Exec 50
Megamergers shook up the industry in 2009, shuffling the deck of pharma’s top companies. Find out which companies emerged on top, who might be next, and how those best positioned to weather a challenging business environment are poised to rip the rankings apart over the next few years
Emerging Pharma Leaders 2010
Strong, skilled management is on the agenda as never before. Find out who made 2010's roster of high-potential change masters—and how they plan to lead the industry through the turbulent times ahead.
|
|
|
|
B2M Productions/Getty Images
|
|
|
|
